Trending News
News

News
Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinson's Disease
The annual MJFF program will provide intellectual and financial resources to help push potential PD drug targets forward toward clinical trials.

News
Lab21 Expands Companion Diagnostic Cancer Testing Service Internationally
Lab21 now offer its K-RAS gene mutation and its epidermal growth factor receptor mutation testing services to its international customers.

News
Calibrant Biosystems Announces Cooperative R&D Agreement with the Armed Forces Institute of Pathology
The collaboration will leverage Calibrant’s proteomic technologies for evaluating and validating protein markers for AFIP.

News
Boehringer Ingelheim Licenses Drug Targets from Autoimmune Collaboration with BioFocus DPI
Boehringer Ingelheim has exercised its right to license two drug targets that results in a milestone payment for BioFocus DPI.

News
Thermo Fisher Scientific Acquires Affinity BioReagents
Broad range of antibody products expands Thermo Fisher’s protein-research offering.

News
PTC Therapeutics Announces $25 Million Award from Cystic Fibrosis Foundation Therapeutics
Expanded collaboration supports pivotal Phase 2b clinical trials of first potential therapy to address an underlying cause of cystic fibrosis.

News
Invitrogen Corporation and BioTek Instruments Announce Strategic Collaboration
The agreement aims to validate the compatibility of Invitrogen’s reagents and technology platforms with BioTek’s microplate detection instruments.

News
Heart Disease Specialists Meet Spanish Footballers to Develop Tools for Detecting Sudden Death Syndrome
The main objective of the symposium hosted by Applied Biosystems was to develop a new test for predicting molecular or genetic changes in sudden death.

News
Work Flows from Advanced Large-Scale Methods for Measuring Proteins
Researchers have created the most comprehensive “parts list” to date for mitochondria, a compendium that includes nearly 1,100 proteins.

News
Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines with Preliminary Human Data
Preliminary clinical trial data demonstrating that DNA vaccines can safely achieve significant immune responses against H5N1 pandemic influenza in humans.
Advertisement